Scientists argue for more FDA oversight of healthcare AI tools
Peer-Reviewed Publication
This month, we’re focusing on artificial intelligence (AI), a topic that continues to capture attention everywhere. Here, you’ll find the latest research news, insights, and discoveries shaping how AI is being developed and used across the world.
Updates every hour. Last Updated: 18-Nov-2025 05:11 ET (18-Nov-2025 10:11 GMT/UTC)
An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical technologies. That is the takeaway from a new report issued to the FDA, published this week in the open-access journal PLOS Medicine by Leo Celi of the Massachusetts Institute of Technology, and colleagues.
A new study led by Tulane University researchers reveals that generative AI tools, such as ChatGPT, can enhance employees' creativity — but only if they know how to think critically about their own work and utilize the tools effectively.
This release has been removed upon request of the submitting institution. Please contact Ben Schamisso, ben.schamisso@northwestern.edu for more information.
MIT researchers developed a computationally efficient method that could enable artists to design realistic simulations of elastic objects, like bouncy or squishy characters, for animated movies or video games.